APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 72 filers reported holding APTOSE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $336,000 | -19.8% | 565,000 | 0.0% | 0.50% | -17.2% |
| Q2 2022 | $419,000 | -45.4% | 565,000 | 0.0% | 0.61% | -24.2% |
| Q1 2022 | $768,000 | +0.7% | 565,000 | 0.0% | 0.80% | +14.7% |
| Q4 2021 | $763,000 | -53.3% | 565,000 | -24.7% | 0.70% | -51.9% |
| Q3 2021 | $1,635,000 | -29.6% | 750,000 | +7.1% | 1.46% | -25.4% |
| Q2 2021 | $2,324,000 | -43.6% | 700,000 | +1.4% | 1.95% | -46.2% |
| Q1 2021 | $4,123,000 | +25.5% | 690,000 | -8.0% | 3.63% | +25.2% |
| Q4 2020 | $3,285,000 | -21.8% | 750,000 | +7.1% | 2.90% | -36.6% |
| Q3 2020 | $4,200,000 | +10.9% | 700,000 | +16.7% | 4.57% | +6.7% |
| Q2 2020 | $3,786,000 | +6.2% | 600,000 | 0.0% | 4.28% | -10.7% |
| Q1 2020 | $3,564,000 | -7.6% | 600,000 | -11.8% | 4.80% | +16.7% |
| Q4 2019 | $3,856,000 | +269.7% | 680,000 | +36.0% | 4.11% | +216.0% |
| Q3 2019 | $1,043,000 | – | 500,000 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 2,900,000 | $12,702,000 | 3.02% |
| P.A.W. CAPITAL CORP | 750,000 | $3,285,000 | 2.90% |
| Prosight Management, LP | 824,795 | $3,613,000 | 1.67% |
| Voss Capital, LLC | 715,000 | $3,132,000 | 1.58% |
| DRW Securities, LLC | 7,976,176 | $34,936,000 | 1.23% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $6,172,000 | 1.06% |
| Nantahala Capital Management | 7,272,673 | $31,854,000 | 0.99% |
| SANDERS MORRIS HARRIS LLC | 925,153 | $4,231,000 | 0.96% |
| PRECEPT MANAGEMENT LLC | 440,696 | $1,930,000 | 0.78% |
| Endurant Capital Management LP | 477,895 | $2,093,000 | 0.76% |